Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Genitourinary 1

Conditions

Renal Insufficiency, Chronic 1Polycystic Kidney, Autosomal Dominant 1Hypertension 1Hematologic Neoplasms 1Chronic Kidney Disease-Mineral and Bone Disorder 1

Interventions

pembrolizumab 563Specimen Handling 493Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 405Radiotherapy 353Bevacizumab 314Gemcitabine 313Paclitaxel 298Biopsy 292Drug Therapy 284Blood Specimen Collection 248Capecitabine 246Oxaliplatin 241fludarabine 239Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 188Radiosurgery 182Standard of Care 159Rituximab 159Pemetrexed 156Surgical Procedures, Operative 148atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Polymorphism, Genetic × Clear all
NCT06416761 2024-05-16

Genetics in the Progression of Nephropathies

Ospedale San Raffaele

Recruiting
10,000 enrolled
GenitourinaryOther hematologic neoplasm

Hypertension, Chronic Kidney Disease-Mineral and Bone Disorder, Polycystic Kidney, Autosomal Dominant, Hematologic Neoplasms, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡